OI Onconetix, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Onconetix, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3m. The latest transaction was disclosed on 22 April 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. The full history is free.
€122,698
3 ops.
Sell Volume
Buys €129,543 €122,698 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2026
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
▼ 10% Owner · Executives · 21 Apr 2026
49,710 shares @ US$0.69 0.84% mcap 11.6% of flow Class A Shares SEC:0001475597-26-000019:0
▼ 10% Owner · Executives · 16 Apr 2026
53,867 shares @ US$0.73 0.96% mcap 13.2% of flow Class A Shares SEC:0001475597-26-000018:0
▲ 10% Owner · Executives · 17 Apr 2026
34,636 shares @ US$0.73 0.62% mcap 8.5% of flow Class A Shares SEC:0001475597-26-000018:1
Canonical exit: 16 Jul 2026 (T+90) ▼ 10% Owner · Executives · 20 Apr 2026
94,462 shares @ US$0.75 1.74% mcap 23.8% of flow Class A Shares SEC:0001475597-26-000018:2
▲ 10% Owner · Executives · 14 Apr 2026
74,350 shares @ US$0.77 1.40% mcap 19.2% of flow Class A Shares SEC:0001475597-26-000017:0
Canonical exit: 13 Jul 2026 (T+90) ▲ 10% Owner · Executives · 15 Apr 2026
92,554 shares @ US$0.76 1.72% mcap 23.6% of flow Class A Shares SEC:0001475597-26-000017:1
Canonical exit: 14 Jul 2026 (T+90) ● Director · Executives · 15 Aug 2025
39 shares 0Common Stock SEC:0001213900-25-078488:0
● Director · Executives · 15 Aug 2025
39 shares 0Common Stock SEC:0001213900-25-078484:0
● Director · Executives · 15 Aug 2025
20 shares 0Common Stock SEC:0001213900-25-078489:0
● Director · Executives · 15 Aug 2025
39 shares 0Common Stock SEC:0001213900-25-078487:0
241,514 shares Common Stock SEC:0001415889-25-019831:0
◆ Director · Executives · 23 Mar 2025
1,709 shares 0Common Stock SEC:0001013762-25-002105:0
◆ Interim CEO, CSO · Executives · 20 Dec 2024
177,462 shares 0Common Stock SEC:0001213900-25-005492:0
◆ Chief Strategy Officer · Executives · 20 Dec 2024
177,462 shares 0Common Stock SEC:0001213900-25-005491:0
◆ Director · Executives · 26 Sept 2024
3,318 shares 0Common Stock SEC:0001213900-24-083523:0
◆ Director · Executives · 26 Sept 2024
3,318 shares 0Common Stock SEC:0001213900-24-083520:0
◆ Director · Executives · 26 Sept 2024
3,318 shares 0Common Stock SEC:0001213900-24-083522:0
◆ Director · Executives · 26 Sept 2024
3,318 shares 0Common Stock SEC:0001213900-24-083521:0
◆ Director · Executives · 26 Sept 2024
3,318 shares 0Common Stock SEC:0001213900-24-083524:0
◆ Interim CEO & CSO · Executives · 24 Sept 2024
489,160 shares Common Stock SEC:0001213900-24-082238:0
◆ Chief Strategy Officer · Executives · 24 Sept 2024
428,010 shares Common Stock SEC:0001213900-24-082239:0
◆ Director · Executives · 16 Feb 2024
3,125 shares 0Common Stock SEC:0001213900-24-015752:0
关于 Onconetix, Inc. Onconetix, Inc. 是一家在 XNAS 市场上市的公司,专注于开发癌症诊断的创新解决方案。它致力于改进肿瘤疾病的早期检测方法。